In today’s oncology landscape, new oral chemotherapy medications or updated indications are being released at an increasing rate. With each approval comes new hope for individuals and their families for a road to remission, and also a constantly-changing environment for their healthcare provider to navigate to stay on top of these medications and treatment plans.
That is why Avella has dedicated the latest edition of our publication Dispensing Excellence to oral oncology and included our Oral Chemotherapy Monitoring and Counseling Chart. This edition contains:
- Information on more than 75 medications for the treatment of liquid and solid tumors, many of them in limited distribution
- Dose, FDA indication, formulation, mechanism of action, monitoring parameters and key counseling points for each medication
- A digital version of the chart, available through our Oral Oncology Medication Guide Mobile app
- An introduction letter from Avella CEO, Rebecca Shanahan
We invite you to explore our latest issue today to access this valuable chart for oncology providers and practices and download the mobile app for more frequently updated medication information. This issue of Dispensing Excellence is just one way Avella is working hard to alleviate the burden on healthcare professionals and improve patient health and outcomes.
Download the app on your platform of choice:
